Angela Stoller
Family · Greenville, SCNPI 1043244023
Payments from drug & device makers
Across 193 payments — averaging $18.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Novo Nordisk$437
- Galderma Laboratories, L.p.$374
- Currax Pharmaceuticals LLC$194
- Lilly USA, LLC$190
- Bayer$136
- plus $1K from 22 others
What the payments were for
- Food & beverage$3,551100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 63 | $1,186 |
| Novo Nordisk | 39 | $437 |
| Galderma Laboratories, L.p. | 4 | $374 |
| Currax Pharmaceuticals LLC | 18 | $194 |
| Lilly USA, LLC | 7 | $190 |
| Bayer | 2 | $136 |
| Biohaven Pharmaceuticals, Inc. | 6 | $133 |
| Pfizer | 8 | $131 |
| AstraZeneca | 8 | $128 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $95 |
| Biohaven Pharmaceutical Holding Company Ltd. | 6 | $95 |
| GSK | 5 | $68 |
| Dexcom, Inc. | 3 | $52 |
| Exact Sciences | 2 | $37 |
| Amneal Pharmaceuticals LLC | 2 | $36 |
| Antares Pharma, Inc. | 2 | $35 |
| Abbott | 2 | $35 |
| Hikma Pharmaceuticals USA | 1 | $24 |
| Eyevance Pharmaceuticals LLC | 1 | $24 |
| Astellas Pharma US Inc | 1 | $19 |
| Amarin Pharma, Inc. | 1 | $18 |
| Esperion Therapeutics, Inc. | 1 | $18 |
| IBSA Pharma Inc. | 1 | $17 |
| Lundbeck LLC | 1 | $16 |
| Eisai Inc. | 1 | $15 |
| Upsher-smith Laboratories LLC | 1 | $14 |
| Boehringer Ingelheim | 1 | $14 |
| Lupin Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,551 in reported general payments places this provider in the 85th percentile of 3,248 family providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 64 | $56,348 |
| JardianceEmpagliflozin | 39 | $32,315 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 182 | $28,076 |
| MounjaroTirzepatide | 24 | $26,115 |
| RybelsusSemaglutide | 18 | $24,064 |
| SuboxoneBuprenorphine Hcl/Naloxone Hcl | 25 | $19,236 |
| SynthroidLevothyroxine Sodium | 11 | $1,084 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 19 | $949 |
| Duloxetine Hcl | 55 | $834 |
| Levothyroxine Sodium | 84 | $658 |
| Gabapentin | 43 | $636 |
| Fluoxetine Hcl | 24 | $546 |
| Rosuvastatin Calcium | 78 | $449 |
| Omeprazole | 29 | $350 |
| Bupropion XlBupropion Hcl | 22 | $345 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $437 | $80,41182 claims |
| Boehringer IngelheimJardiance | $14 | $32,31539 claims |
| Hikma Pharmaceuticals USABuprenorphine-Naloxone | $24 | $28,076182 claims |
| Lilly USA, LLCMounjaro | $190 | $26,11524 claims |
| AbbVieSynthroid | $1,186 | $1,08411 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $36 | $65884 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,248 family providers in South Carolina.
Other family in Greenville
- Alison FogartyGreenville$2M
- Sara ChristieGreenville$229K
- Carrie HendersonGreenville$91K
- Michelle StrongGreenville$55K
- Melissa BrownlowGreenville$20K
- Sarah McNightGreenville$15K
- Melissa MotesGreenville$13K
- Matthew KeatonGreenville$10K
- Kara Cooper GilmerAnderson$127K
- Jessica BellEasley$96K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.